Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00109967
Status:
COMPLETED
Last Update Posted:
2014-04-17
First Post:
2005-05-03
Brief Title:
CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Mantle Cell Lymphoma |
Keywords: